The majority of studies suggest that AR expression in ER+ breast cancer is associated with a favorable prognosis [449,450]; however, other studies do not support a prognostic and predictive value of AR expression in ER+ breast cancer [451]. Here, ESR1 is linked to breast carcinoma.